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Abstract
Cardiac surgery has been scrutinized and challenged as no other specialty has. That has brought new ideas and
structural frameworks but has also brought uncertainty and scepticism.
This report identifies the challenges that the specialty is facing, and suggests solutions and strategies for the future.
Introduction
Within the last 50 years, the steps of progress in the
medical field are impressive: The 5-year cancer survival
rates have risen from 30% to over 60% [1]. Cardiovascular
mortality between 1950 and 1990 has decreased by about
the same number & HIV/AIDS has been transformed
into a chronic disease [1]. Life expectancy for a 45-year-
old has increased 9 years since 1950 [2].
On the other hand, in the US only, it has been estimated
that the number of citizens over the age of 75 is expected
to quadruple over the next 50 years [3]; furthermore, IHD
is the leading cause of death and in UK accounts for 17.4%
of all deaths annually. IHD accounted for approximately
one in six male deaths and one in eight female deaths dur-
ing 2009 [4]. So, although the predictions outline the
increased future demand of Cardiothoracic surgery, the
specialty has witnessed a notable decrease in applicants
over the past decade. In this context, Grover and collea-
gues [5] reported that the “United States will face a severe
shortage of cardiothoracic surgeons within 10 years if
entry into the profession keeps declining.’
The problem
There is a lack of interest amongst young trainees for
the cardiothoracic specialty and since 2003 the number
of recruiters in the specialty is reducing annually.
The reason for this discrepancy is multifaceted.
Aetiology
1) Coronary Stent technology has grown larger and has
displaced Coronary Artery Bypass surgery globally; In the
British Isles, three PCIs are carried out per surgically
revascularised case; Furthermore, Intravascular procedures
continue to evolve not only with the use of intracoronary
stents but also with the introduction of such a technology
for the treatment of aortic pathologies and valvular heart
disease.
Each year patients who undergo cardiac surgery con-
tinue to be sicker, older, and at higher risk for complica-
tions. As patients get sicker and hear about advancing
technology, they are more likely to have unrealistic
expectations.
2) There is a lack of strong links between innovative
research and clinical practice.
Despite this eruption of ideas, the uptake of change
amongst the surgical fraternity is variable. Undoubtfully,
there is a skepticism amongst the surgical community of
accepting new ideas and implement them, especially
when the data to support new concepts are low level of
evidence, due to lack of randomize control trials. On
the other hand there is the claim, that in order to man-
age the uncertainties of innovation one should imple-
ment surgery in a more scientific way, by drawing on
the ideas of control, rationality, objectivity, and predict-
ability [6].
3) Within the specialty they would be examples of
practitioners focusing on personal development at the
expense of training, or on the other hand Personal devel-
opment and training slows down or even arrests after
completion of training and lastly sometimes there is a
reluctance of Senior practitioners to learn new techni-
ques but that should not be allowed to block innovative
practice.
4) There is a growing separation of cardiac surgery
from the diagnostic process; therefore the algorithms of
the treatment of three vessel disease are not well
embraced by the practitioners treating those patients,
resulting for example, 30% more ad hoc PCI to be car-
ried out without robust indications [7].
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So, how should cardiac surgery deal with the fact that
technology changes rapidly, and that the potential thera-
peutic options for patients increase faster than prospec-
tive trials can evaluate them?
Suggested solutions
Academic surgery is based on written evidence derived
from prospective trials, meta-analyses, or published
guidelines, edited by medical societies and this has been
the cornerstones of the evolution of Cardiac surgery.
However there is a need of pursuing academism in a
more dynamic fashion; this should be matched with a
need for a change in our professional behaviour, from the
individual to the team approach of care. In fact, the entire
culture of academic medicine is moving away from indi-
vidualism. The tertiary care world is shifting from the
achievements of individual experts toward cooperation
between individuals and groups.
I urge for an attitude model of altruism and leadership:
altruistic leadership based on the motivation behind
helping. I suggest a model “back to the real virtues” of a
commitment to leadership, scholarship, mentoring, and
quality patient care.
We are surrounded by talented, highly committed
individuals who want to be part of a successful team;
however we need to move towards an attitude where
group trust is as strong force as individual trust.
How?
A multifaceted approach has to be adapted, by improving
cardiothoracic surgical resident education, developing
innovative techniques for both resident and postgraduate
education (including diversification of key clinical skill
sets to include catheter-based training and simulation/
electronic learning as learning tools), and redesigning the
current resident training paradigm.
The development of an educational body with a specific
task to broaden the appeal of cardiothoracic training to
new recruits, should be considered. The duty of such a
body should be focus in investigating avenues of increased
exposure for the cardiothoracic specialty, including a
greater internet presence not only on professional society
Web sites but also on contemporary social Web sites,
such as “Facebook” or direct marketing the High schools.
This should be an effort on attracting “high-calibre indivi-
duals or “The Best and the Brightest” as per Kim et al [8].
Finally, there is evidence that “established, mature”
cardiothoracic surgeons can play a very powerful role
simply through their interactions with students at any
level.
There is also clear evidence [9] that academic mentor-
ing of medical students in their early formative years
has a profound effect on guiding them into surgery as a
career choice.
What is the future of Cardiac Surgery?
Although, the answer brings to mind futuristic technol-
ogy, I think that the future needs to be laid with care, by
taking on board the lessons of the past; the innovation has
to be bridged to the clinical practise. This could be
achieved by linking the basic research to its clinical appli-
cation (translational medical research) by ensuring for
example, that Academic leaders take up new roles in the
health service. The result is that world-class researchers
work alongside their clinical counterparts to ensure that
research and education inform and are informed by, clini-
cal need. [10]. The Academic Health Science Centre
model, which is a partnership between a healthcare provi-
der and a University, may be the way forward.
Predictions for the future
There is a suspicion on implementing new technology:
McKinlay [11] argued that many, if not most, innovations
in medicine undergo a process of which assessment of
effectiveness is only a late stage placing many patients at
risk of receiving treatments which are useless or malign.
So, how does a society decide which new medicines,
technologies and tests should become available to all of its
citizens? How do these national decisions fit into and
affect a global pattern of healthcare delivery?
I would propose that only education and scientific
backup would allow authorities to overcome hesitancy on
taking up new ideas and innovative practices. Educating
health members, aids to eliminate the gap between practi-
tioners: For the older to become familiar with the new
technology and for the younger to learn from previous
experience.
Finally, a word of caution: Currently, significant and
often unperceived conflicts of interest exist for everyone
involved in delivering health care, and hence it is difficult
for the patient to make a well- informed opinion. The
answer to this problem may be the formation of “Interdis-
ciplinary working groups” in order to facilitate robust
informed consents and patients education.
The specialty of cardiac surgery has come a long way,
and now it stands between crossroads. The future is the
new recruiters, the young learners; in order to get the best
out of them, teachers must teach differently. New technol-
ogy and skill sets are necessary for thoracic surgery to
grow and flourish. We must change even though change is
not easy.
We are on the threshold of a brave new world in which
the measurement of surgical performance will no longer
be peripheral to our work, but an integral part of it.
Conclusion
Innovation studies probably fallen out of “fashion” with an
interest in new technologies and how they were validated;
the fear on implementing innovational new ideas should
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be tackled with educational, critical mind. Robust level of
evidence derives from multi-centre prospective rando-
mized trials. Authorities and medical practitioners should
be working towards implementing those principles.
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